Literature DB >> 18719909

Diagnostic value of PET/CT for the staging and restaging of pediatric tumors.

Margit Kleis1, Heike Daldrup-Link, Katherine Matthay, Robert Goldsby, Ying Lu, Tibor Schuster, Carole Schreck, Philip W Chu, Randall A Hawkins, Benjamin L Franc.   

Abstract

OBJECTIVE: The objective of this retrospective study was to compare the diagnostic value of 2-[(18)F]fluoro-2-deoxy-D: -glucose positron emission tomography ((18)F-FDG PET)/CT versus (18)F-FDG PET and CT alone for staging and restaging of pediatric solid tumors.
METHODS: Forty-three children and adolescents (19 females and 24 males; mean age, 15.2 years; age range, 6-20 years) with osteosarcoma (n = 1), squamous cell carcinoma (n = 1), synovial sarcoma (n = 2), germ cell tumor (n = 2), neuroblastoma (n = 2), desmoid tumor (n = 2), melanoma (n = 3), rhabdomyosarcoma (n = 5), Hodgkin's lymphoma (n = 7), non-Hodgkin-lymphoma (n = 9), and Ewing's sarcoma (n = 9) who had undergone (18)F-FDG PET/CT imaging for primary staging or follow-up of metastases were included in this study. The presence, location, and size of primary tumors was determined separately for PET/CT, PET, and CT by two experienced reviewers. The diagnosis of the primary tumor was confirmed by histopathology. The presence or absence of metastases was confirmed by histopathology (n = 62) or clinical and imaging follow-up (n = 238).
RESULTS: The sensitivities for the detection of solid primary tumors using integrated (18)F-FDG PET/CT (95%), (18)F-FDG PET alone (73%), and CT alone (93%) were not significantly different (p > 0.05). Seventeen patients showed a total of 153 distant metastases. Integrated PET/CT had a significantly higher sensitivity for the detection of these metastases (91%) than PET alone (37%; p < 0.05), but not CT alone (83%; p > 0.05). When lesions with a diameter of less than 0.5 cm were excluded, PET/CT (89%) showed a significantly higher specificity compared to PET (45%; p < 0.05) and CT (55%; p < 0.05). In a sub-analysis of pulmonary metastases, the values for sensitivity and specificity were 90%, 14%, 82% and 63%, 78%, 65%, respectively, for integrated PET/CT, stand-alone PET, and stand-alone CT. For the detection of regional lymph node metastases, (18)F-FDG PET/CT, (18)F-FDG PET alone, and CT alone were diagnostically correct in 83%, 61%, and 42%. A sub-analysis focusing on the ability of PET/CT, PET, and CT to detect osseous metastases showed no statistically significant difference between the three imaging modalities (p > 0.05).
CONCLUSION: Our study showed a significantly increased sensitivity of PET/CT over that of PET for the detection of distant metastases but not over that of CT alone. However, the specificity of PET/CT for the characterization of pulmonary metastases with a diameter > 0.5 cm and lymph node metastases with a diameter of <1 cm was significantly increased over that of CT alone.

Entities:  

Mesh:

Year:  2008        PMID: 18719909     DOI: 10.1007/s00259-008-0911-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  45 in total

1.  CT in PET/CT: essential features of interpretation.

Authors:  Heiko Schöder; Henry W D Yeung; Steven M Larson
Journal:  J Nucl Med       Date:  2005-08       Impact factor: 10.057

2.  PET/CT with diagnostic CT in the evaluation of childhood sarcoma.

Authors:  Christiane Franzius; Kai U Juergens; Josef Vormoor
Journal:  AJR Am J Roentgenol       Date:  2006-02       Impact factor: 3.959

3.  Quantitative effects of contrast enhanced CT attenuation correction on PET SUV measurements.

Authors:  Tira Bunyaviroch; Timothy G Turkington; Terence Z Wong; John W Wilson; James G Colsher; R Edward Coleman
Journal:  Mol Imaging Biol       Date:  2007-12-21       Impact factor: 3.488

4.  Correction of oral contrast artifacts in CT-based attenuation correction of PET images using an automated segmentation algorithm.

Authors:  Alireza Ahmadian; Mohammad R Ay; Javad H Bidgoli; Saeed Sarkar; Habib Zaidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-17       Impact factor: 9.236

5.  Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.

Authors:  H E Daldrup-Link; C Franzius; T M Link; D Laukamp; J Sciuk; H Jürgens; O Schober; E J Rummeny
Journal:  AJR Am J Roentgenol       Date:  2001-07       Impact factor: 3.959

6.  PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.

Authors:  A K Berthelsen; S Holm; A Loft; T L Klausen; F Andersen; L Højgaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-05-21       Impact factor: 9.236

7.  Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules?

Authors:  K U Juergens; M Weckesser; L Stegger; C Franzius; M Beetz; O Schober; W Heindel; D Wormanns
Journal:  Eur Radiol       Date:  2006-02-01       Impact factor: 5.315

8.  Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.

Authors:  Y Sugawara; S J Fisher; K R Zasadny; P V Kison; L H Baker; R L Wahl
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

9.  Improved non-invasive T-Staging in non-small cell lung cancer by integrated 18F-FDG PET/CT.

Authors:  S Pauls; A K Buck; K Hohl; G Halter; M Hetzel; N M Blumstein; F M Mottaghy; G Glatting; S Krüger; L Sunder-Plassmann; P Möller; V Hombach; H-J Brambs; S N Reske
Journal:  Nuklearmedizin       Date:  2007       Impact factor: 1.379

10.  Role of iodine-131 MIBG scanning in the management of paediatric patients with neuroblastoma.

Authors:  G M Shah Syed; H Naseer; G N Usmani; M A Cheema
Journal:  Med Princ Pract       Date:  2004 Jul-Aug       Impact factor: 1.927

View more
  41 in total

Review 1.  PET/CT in paediatric oncology: clinical usefulness and dosimetric concerns.

Authors:  Giovanni Lucignani; Diego De Palma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01       Impact factor: 9.236

Review 2.  Combined PET/MRI: a new dimension in whole-body oncology imaging?

Authors:  Gerald Antoch; Andreas Bockisch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

Review 3.  Imaging pediatric bone sarcomas.

Authors:  Sue C Kaste
Journal:  Radiol Clin North Am       Date:  2011-06-16       Impact factor: 2.303

4.  Use of PET/CT instead of CT-only when planning for radiation therapy does not notably increase life years lost in children being treated for cancer.

Authors:  Josefine S Kornerup; Patrik Brodin; Charlotte Birk Christensen; Thomas Björk-Eriksson; Anne Kiil-Berthelsen; Lise Borgwardt; Per Munck Af Rosenschöld
Journal:  Pediatr Radiol       Date:  2014-11-07

5.  Artificial intelligence in musculoskeletal oncological radiology.

Authors:  Matjaz Vogrin; Teodor Trojner; Robi Kelc
Journal:  Radiol Oncol       Date:  2020-11-10       Impact factor: 2.991

6.  Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI.

Authors:  Ashok J Theruvath; Florian Siedek; Anne M Muehe; Jordi Garcia-Diaz; Julian Kirchner; Ole Martin; Michael P Link; Sheri Spunt; Allison Pribnow; Jarrett Rosenberg; Ken Herrmann; Sergios Gatidis; Jürgen F Schäfer; Michael Moseley; Lale Umutlu; Heike E Daldrup-Link
Journal:  Radiology       Date:  2020-05-05       Impact factor: 11.105

7.  The clinical impact of 18F-FDG PET/CT in extracranial pediatric germ cell tumors.

Authors:  Adam Hart; Reza Vali; Eman Marie; Furqan Shaikh; Amer Shammas
Journal:  Pediatr Radiol       Date:  2017-06-29

8.  How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach.

Authors:  Anne M Muehe; Ashok J Theruvath; Lillian Lai; Maryam Aghighi; Andrew Quon; Samantha J Holdsworth; Jia Wang; Sandra Luna-Fineman; Neyssa Marina; Ranjana Advani; Jarrett Rosenberg; Heike E Daldrup-Link
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

9.  Unusual association of alveolar rhabdomyosarcoma with pancreatic metastasis: emerging role of PET-CT in tumor staging.

Authors:  Priyanka Jha; Andreas M J Frölich; Beth McCarville; Oscar M Navarro; Paul Babyn; Robert Goldsby; Heike Daldrup-Link
Journal:  Pediatr Radiol       Date:  2010-02-24

Review 10.  Nuclear medicine and multimodality imaging of pediatric neuroblastoma.

Authors:  Wolfgang Peter Mueller; Eva Coppenrath; Thomas Pfluger
Journal:  Pediatr Radiol       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.